Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Files Suit Seeking Payments from Shuttered DNAPrint

NEW YORK (GenomeWeb News) – Illumina has filed a lawsuit against DNAPrint Genomics and its Ellipsis Biotherapeutics subsidiary seeking payment for products Illumina shipped to the firm in 2007-2008.

According to the suit, which was filed last week in the US District Court for the Southern District of California, Illumina is seeking nearly $275,000 in payments from DNAPrint Genomics for genotyping kits and DNA analysis kits that it ordered from Illumina and didn't pay for, as stipulated under a contract between the firms in April 2007.

As reported by GenomeWeb Daily News two weeks ago, DNAPrint Genomics shut down its operations sometime in February or early March.

Between December 2006 and June 2008, DNAPrint entered into nine separate purchase order contracts with Illumina. The suit alleges that although Illumina provided all of the products under the agreements, DNAPrint never made payments on the products.

Illumina has demanded a jury trial seeking payment of the full amount due, plus interest and the award of attorneys' fees.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.